Welkom bij Scalda & Bohn Stafleu van Loghum
Scalda heeft ervoor gezorgd dat je Mijn BSL eenvoudig en snel kunt raadplegen.Je kunt de producten hieronder links aanschaffen en rechts inloggen.
Gepubliceerd in:
2021 | OriginalPaper | Hoofdstuk
2. Medische diagnostiek
Auteurs : Robert Damstra, PhD, MD, Kristiana Gordon, PhD, MD, Malou van Zanten, PhD, PT, Sahar Mansour, PhD, MD, Kirsten van Duinen, MD, Sarah Thomis, MSc, Nele Devoogdt, PhD, PT, Inge Fourneau, PhD, MD, Sjan Lavrijsen, PhD, MD, Wendemagegn Enbiale, MD, Michette de Rooij, PhD, MD
Gepubliceerd in: Oedeem en oedeemtherapie
Uitgeverij: Bohn Stafleu van Loghum
share
DELEN
Deel dit onderdeel of sectie (kopieer de link)
-
Optie A:
-
Optie B:Deel de link per e-mail
Samenvatting
Medische diagnostiek vormt de basis voor de analyse van zwelling. Er wordt veel aandacht besteed aan de aspecten rond secundair lymfoedeem, mede in relatie met het uitlokkend moment, zoals een oncologische behandeling, filariasis, podoconiosis, erysipelas of overgewicht. Ook wordt besproken dat primair lymfoedeem geen diagnose is en de oude (tijdsgebonden) indeling in congenitaal, precox en tarda wordt verlaten. Middels een speciaal algoritme wordt de work-up bij verdenking van aangeboren lymfoedeem/vasculaire malformatie gepresenteerd waarbij de verschillende genetische afwijkingen worden doorgenomen. Zorgvuldige feno- en genotypering zijn hierbij essentieel. Ook kan zwelling door een veneuze pathologie worden verklaard. Door een systematische benadering van anamnese, lichamelijk en aanvullend onderzoek krijgt u een helder en praktisch beeld van de medische diagnostiek van zwelling. Er is een speciaal hoofdstuk voor huidafwijkingen bij en door lymfoedeem. Het hele hoofdstuk is rijk geïllustreerd met fotomateriaal.
Log in om toegang te krijgen
Literatuur
1.
go back to reference Moffatt CJ, Keeley V, Franks PJ, et al. Chronic oedema: a prevalent health care problem for UK health services. Int Wound J. 2017;14(5):772–81. https://doi.org/10.1111/iwj.12694 [published Online First: 2016/12/06].
Moffatt CJ, Keeley V, Franks PJ, et al. Chronic oedema: a prevalent health care problem for UK health services. Int Wound J. 2017;14(5):772–81. https://doi.org/10.1111/iwj.12694 [published Online First: 2016/12/06].
2.
go back to reference Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med (Lond). 2004;4(5):448–53. https://doi.org/10.7861/clinmedicine.4-5-448 [published Online First: 2004/11/13].
Mortimer PS, Levick JR. Chronic peripheral oedema: the critical role of the lymphatic system. Clin Med (Lond). 2004;4(5):448–53. https://doi.org/10.7861/clinmedicine.4-5-448 [published Online First: 2004/11/13].
3.
go back to reference Angeli V, Randolph GJ. Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol. 2006;4(4):217–28. https://doi.org/10.1089/lrb.2006.4406 [published Online First: 2007/03/31].
Angeli V, Randolph GJ. Inflammation, lymphatic function, and dendritic cell migration. Lymphat Res Biol. 2006;4(4):217–28. https://doi.org/10.1089/lrb.2006.4406 [published Online First: 2007/03/31].
4.
go back to reference Tso P, Balint JA. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol. 1986;250(6 Pt 1):G715–26. https://doi.org/10.1152/ajpgi.1986.250.6.g715 [published Online First: 1986/06/01].
Tso P, Balint JA. Formation and transport of chylomicrons by enterocytes to the lymphatics. Am J Physiol. 1986;250(6 Pt 1):G715–26. https://doi.org/10.1152/ajpgi.1986.250.6.g715 [published Online First: 1986/06/01].
5.
go back to reference Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87(2):198–210. https://doi.org/10.1093/cvr/cvq062 [published Online First: 2010/03/05].
Levick JR, Michel CC. Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res. 2010;87(2):198–210. https://doi.org/10.1093/cvr/cvq062 [published Online First: 2010/03/05].
6.
go back to reference International Society of L. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013;46(1):1–11 [published Online First: 2013/08/13].
International Society of L. The diagnosis and treatment of peripheral lymphedema: 2013 Consensus Document of the International Society of Lymphology. Lymphology 2013;46(1):1–11 [published Online First: 2013/08/13].
7.
go back to reference Halk AB, Damstra RJ. First Dutch guidelines on lipedema using the international classification of functioning, disability and health. Phlebology. 2017;32(3):152–59. https://doi.org/10.1177/0268355516639421 [published Online First: 2016/04/15].
Halk AB, Damstra RJ. First Dutch guidelines on lipedema using the international classification of functioning, disability and health. Phlebology. 2017;32(3):152–59. https://doi.org/10.1177/0268355516639421 [published Online First: 2016/04/15].
8.
go back to reference Bertsch T, Erbacher G, Corda D, et al. European best practice of lipedema. European Best Practice of Lipedema. Phlebologie. 2020.
Bertsch T, Erbacher G, Corda D, et al. European best practice of lipedema. European Best Practice of Lipedema. Phlebologie. 2020.
9.
go back to reference Gloviczki P, Driscoll DJ. Klippel-Trenaunay syndrome: current management. Phlebology. 2007;22(6):291–8.
Gloviczki P, Driscoll DJ. Klippel-Trenaunay syndrome: current management. Phlebology. 2007;22(6):291–8.
10.
go back to reference Brakenhielm E, Alitalo K. Cardiac lymphatics in health and disease. Nat Rev Cardiol. 2019;16(1):56–68. https://doi.org/10.1038/s41569-018-0087-8 [published Online First: 2018/10/20].
Brakenhielm E, Alitalo K. Cardiac lymphatics in health and disease. Nat Rev Cardiol. 2019;16(1):56–68. https://doi.org/10.1038/s41569-018-0087-8 [published Online First: 2018/10/20].
11.
go back to reference Tamura R, Yoshida K, Toda M. Current understanding of lymphatic vessels in the central nervous system. Neurosurg Rev. 2019. https://doi.org/10.1007/s10143-019-01133-0 [published Online First: 2019/06/19].
Tamura R, Yoshida K, Toda M. Current understanding of lymphatic vessels in the central nervous system. Neurosurg Rev. 2019. https://doi.org/10.1007/s10143-019-01133-0 [published Online First: 2019/06/19].
12.
go back to reference Vannelli A, Battaglia L, Poiasina E, et al. Pelvic lymphedema: truth or fiction? Med Hypotheses. 2009;72(3):267–70. https://doi.org/10.1016/j.mehy.2008.10.019 [published Online First: 2008/12/17].
Vannelli A, Battaglia L, Poiasina E, et al. Pelvic lymphedema: truth or fiction? Med Hypotheses. 2009;72(3):267–70. https://doi.org/10.1016/j.mehy.2008.10.019 [published Online First: 2008/12/17].
13.
go back to reference Miest RY, Bruce AJ, Comfere NI, et al. A diagnostic approach to recurrent orofacial swelling: a retrospective study of 104 patients. Mayo Clin Proc. 2017;92(7):1053–60. https://doi.org/10.1016/j.mayocp.2017.03.015 [published Online First: 2017/06/12].
Miest RY, Bruce AJ, Comfere NI, et al. A diagnostic approach to recurrent orofacial swelling: a retrospective study of 104 patients. Mayo Clin Proc. 2017;92(7):1053–60. https://doi.org/10.1016/j.mayocp.2017.03.015 [published Online First: 2017/06/12].
14.
go back to reference Eber AE, Mlacker S, Verne S, et al. Morbihan disease complicated by dermatosis neglecta: an unique presentation. J Cutan Pathol. 2017;44(5):470–73. https://doi.org/10.1111/cup.12902 [published Online First: 2017/01/18].
Eber AE, Mlacker S, Verne S, et al. Morbihan disease complicated by dermatosis neglecta: an unique presentation. J Cutan Pathol. 2017;44(5):470–73. https://doi.org/10.1111/cup.12902 [published Online First: 2017/01/18].
15.
go back to reference Nozicka Z. Endovasal granulomatous lymphangiitis as a pathogenetic factor in cheilitis granulomatosa. J Oral Pathol. 1985;14(5):363–5. https://doi.org/10.1111/j.1600-0714.1985.tb00506.x [published Online First: 1985/05/01].
Nozicka Z. Endovasal granulomatous lymphangiitis as a pathogenetic factor in cheilitis granulomatosa. J Oral Pathol. 1985;14(5):363–5. https://doi.org/10.1111/j.1600-0714.1985.tb00506.x [published Online First: 1985/05/01].
16.
go back to reference White MI, Smart LM, Macgregor DM, et al. Recurrent facial oedema associated with a silicone-rubber implant. Br J Dermatol. 1991;125(2):183–5. https://doi.org/10.1111/j.1365-2133.1991.tb06069.x [published Online First: 1991/08/01].
White MI, Smart LM, Macgregor DM, et al. Recurrent facial oedema associated with a silicone-rubber implant. Br J Dermatol. 1991;125(2):183–5. https://doi.org/10.1111/j.1365-2133.1991.tb06069.x [published Online First: 1991/08/01].
17.
go back to reference Saha M, Edmonds E, Martin J, et al. Penile lymphoedema in association with asymptomatic Crohn’s disease. Clin Exp Dermatol. 2009;34(1):88–90. https://doi.org/10.1111/j.1365-2230.2008.02762.x [published Online First: 2008/12/17].
Saha M, Edmonds E, Martin J, et al. Penile lymphoedema in association with asymptomatic Crohn’s disease. Clin Exp Dermatol. 2009;34(1):88–90. https://doi.org/10.1111/j.1365-2230.2008.02762.x [published Online First: 2008/12/17].
18.
go back to reference Huang Q, Ge BJ, Liu LM, et al. Successful management of chylous ascites with total parenteral nutrition, somatostatin, and fibrin glue. Chin Med J (Engl). 2007;120(20):1847–9 [published Online First: 2007/11/22].
Huang Q, Ge BJ, Liu LM, et al. Successful management of chylous ascites with total parenteral nutrition, somatostatin, and fibrin glue. Chin Med J (Engl). 2007;120(20):1847–9 [published Online First: 2007/11/22].
19.
go back to reference Chamouard P, Nehme-Schuster H, Simler JM, et al. Videocapsule endoscopy is useful for the diagnosis of intestinal lymphangiectasia. Dig Liver Dis. 2006;38(9):699–703. https://doi.org/10.1016/j.dld.2006.01.027 [published Online First: 2006/03/11].
Chamouard P, Nehme-Schuster H, Simler JM, et al. Videocapsule endoscopy is useful for the diagnosis of intestinal lymphangiectasia. Dig Liver Dis. 2006;38(9):699–703. https://doi.org/10.1016/j.dld.2006.01.027 [published Online First: 2006/03/11].
20.
go back to reference Lund RH, Moritz MW. Complications of Denver peritoneovenous shunting. Arch Surg. 1982;117(7):924–8. https://doi.org/10.1001/archsurg.1982.01380310038009 [published Online First: 1982/07/01].
Lund RH, Moritz MW. Complications of Denver peritoneovenous shunting. Arch Surg. 1982;117(7):924–8. https://doi.org/10.1001/archsurg.1982.01380310038009 [published Online First: 1982/07/01].
21.
go back to reference Sarica M, Gordon K, Van Zanten M, et al. Lymphoscintigraphic abnormalities associated with milroy disease and lymphedema-distichiasis syndrome. Lymphat Res Biol. 2019;17(6):610–19. https://doi.org/10.1089/lrb.2019.0016 [published Online First: 2019/11/14].
Sarica M, Gordon K, Van Zanten M, et al. Lymphoscintigraphic abnormalities associated with milroy disease and lymphedema-distichiasis syndrome. Lymphat Res Biol. 2019;17(6):610–19. https://doi.org/10.1089/lrb.2019.0016 [published Online First: 2019/11/14].
22.
go back to reference Connell FC, Gordon K, Brice G, et al. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013;84(4):303–14. https://doi.org/10.1111/cge.12173 [published Online First: 2013/04/30].
Connell FC, Gordon K, Brice G, et al. The classification and diagnostic algorithm for primary lymphatic dysplasia: an update from 2010 to include molecular findings. Clin Genet. 2013;84(4):303–14. https://doi.org/10.1111/cge.12173 [published Online First: 2013/04/30].
23.
go back to reference Gordon K, Varney R, Keeley V, et al. Update and audit of the St George’s classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis. J Med Genet. 2020. https://doi.org/10.1136/jmedgenet-2019-106084 [published Online First: 2020/05/16].
Gordon K, Varney R, Keeley V, et al. Update and audit of the St George’s classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis. J Med Genet. 2020. https://doi.org/10.1136/jmedgenet-2019-106084 [published Online First: 2020/05/16].
24.
go back to reference Atton G, Gordon K, Brice G, et al. The lymphatic phenotype in Turner syndrome: an evaluation of nineteen patients and literature review. Eur J Hum Genet. 2015;23(12):1634–9. https://doi.org/10.1038/ejhg.2015.41 [published Online First: 2015/03/26].
Atton G, Gordon K, Brice G, et al. The lymphatic phenotype in Turner syndrome: an evaluation of nineteen patients and literature review. Eur J Hum Genet. 2015;23(12):1634–9. https://doi.org/10.1038/ejhg.2015.41 [published Online First: 2015/03/26].
25.
go back to reference Joyce S, Gordon K, Brice G, et al. The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome. Eur J Hum Genet. 2016;24(5):690–6. https://doi.org/10.1038/ejhg.2015.175 [published Online First: 2015/08/06].
Joyce S, Gordon K, Brice G, et al. The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome. Eur J Hum Genet. 2016;24(5):690–6. https://doi.org/10.1038/ejhg.2015.175 [published Online First: 2015/08/06].
26.
go back to reference Ostergaard P, Simpson MA, Mendola A, et al. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. Am J Hum Genet. 2012;90(2):356–62. https://doi.org/10.1016/j.ajhg.2011.12.018 [published Online First: 2012/01/31].
Ostergaard P, Simpson MA, Mendola A, et al. Mutations in KIF11 cause autosomal-dominant microcephaly variably associated with congenital lymphedema and chorioretinopathy. Am J Hum Genet. 2012;90(2):356–62. https://doi.org/10.1016/j.ajhg.2011.12.018 [published Online First: 2012/01/31].
27.
go back to reference Jones GE, Ostergaard P, Moore AT, et al. Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation (MCLMR): review of phenotype associated with KIF11 mutations. Eur J Hum Genet. 2014;22(7):881–7. https://doi.org/10.1038/ejhg.2013.263 [published Online First: 2013/11/28].
Jones GE, Ostergaard P, Moore AT, et al. Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation (MCLMR): review of phenotype associated with KIF11 mutations. Eur J Hum Genet. 2014;22(7):881–7. https://doi.org/10.1038/ejhg.2013.263 [published Online First: 2013/11/28].
28.
go back to reference Fotiou E, Martin-Almedina S, Simpson MA, et al. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015;6:8085. https://doi.org/10.1038/ncomms9085 [published Online First: 2015/09/04].
Fotiou E, Martin-Almedina S, Simpson MA, et al. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015;6:8085. https://doi.org/10.1038/ncomms9085 [published Online First: 2015/09/04].
29.
go back to reference Martin-Almedina S, Martinez-Corral I, Holdhus R, et al. EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis. J Clin Invest. 2016;126(8):3080–8. https://doi.org/10.1172/jci85794 [published Online First: 2016/07/12].
Martin-Almedina S, Martinez-Corral I, Holdhus R, et al. EPHB4 kinase-inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis. J Clin Invest. 2016;126(8):3080–8. https://doi.org/10.1172/jci85794 [published Online First: 2016/07/12].
30.
go back to reference Brice GW, Mansour S, Ostergaard P, et al. Milroy Disease. 2014.
Brice GW, Mansour S, Ostergaard P, et al. Milroy Disease. 2014.
31.
go back to reference Irrthum A, Karkkainen MJ, Devriendt K, et al. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet. 2000;67(2):295–301. https://doi.org/10.1086/303019 [published Online First: 2000/06/17].
Irrthum A, Karkkainen MJ, Devriendt K, et al. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet. 2000;67(2):295–301. https://doi.org/10.1086/303019 [published Online First: 2000/06/17].
32.
go back to reference Gordon K, Schulte D, Brice G, et al. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res. 2013;112(6):956–60. https://doi.org/10.1161/circresaha.113.300350 [published Online First: 2013/02/16].
Gordon K, Schulte D, Brice G, et al. Mutation in vascular endothelial growth factor-C, a ligand for vascular endothelial growth factor receptor-3, is associated with autosomal dominant milroy-like primary lymphedema. Circ Res. 2013;112(6):956–60. https://doi.org/10.1161/circresaha.113.300350 [published Online First: 2013/02/16].
33.
go back to reference Brice G, Mansour S, Bell R, et al. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet. 2002;39(7):478–83. https://doi.org/10.1136/jmg.39.7.478 [published Online First: 2002/07/13].
Brice G, Mansour S, Bell R, et al. Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24. J Med Genet. 2002;39(7):478–83. https://doi.org/10.1136/jmg.39.7.478 [published Online First: 2002/07/13].
34.
go back to reference Fang J, Dagenais SL, Erickson RP, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet. 2000;67(6):1382–8. https://doi.org/10.1086/316915 [published Online First: 2000/11/15].
Fang J, Dagenais SL, Erickson RP, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet. 2000;67(6):1382–8. https://doi.org/10.1086/316915 [published Online First: 2000/11/15].
35.
go back to reference Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43(10):929–31. https://doi.org/10.1038/ng.923 [published Online First: 2011/09/06].
Ostergaard P, Simpson MA, Connell FC, et al. Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome). Nat Genet. 2011;43(10):929–31. https://doi.org/10.1038/ng.923 [published Online First: 2011/09/06].
36.
go back to reference Ferrell RE, Baty CJ, Kimak MA, et al. GJC2 missense mutations cause human lymphedema. Am J Hum Genet. 2010;86(6):943–8. https://doi.org/10.1016/j.ajhg.2010.04.010 [published Online First: 2010/06/12].
Ferrell RE, Baty CJ, Kimak MA, et al. GJC2 missense mutations cause human lymphedema. Am J Hum Genet. 2010;86(6):943–8. https://doi.org/10.1016/j.ajhg.2010.04.010 [published Online First: 2010/06/12].
37.
go back to reference Ostergaard P, Simpson MA, Brice G, et al. Rapid identification of mutations in GJC2 in primary lymphoedema using whole exome sequencing combined with linkage analysis with delineation of the phenotype. J Med Genet. 2011;48(4):251–5. https://doi.org/10.1136/jmg.2010.085563 [published Online First: 2011/01/27].
Ostergaard P, Simpson MA, Brice G, et al. Rapid identification of mutations in GJC2 in primary lymphoedema using whole exome sequencing combined with linkage analysis with delineation of the phenotype. J Med Genet. 2011;48(4):251–5. https://doi.org/10.1136/jmg.2010.085563 [published Online First: 2011/01/27].
38.
go back to reference Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713–33. https://doi.org/10.1002/ajmg.a.36552 [published Online First: 2014/05/02].
Keppler-Noreuil KM, Sapp JC, Lindhurst MJ, et al. Clinical delineation and natural history of the PIK3CA-related overgrowth spectrum. Am J Med Genet A. 2014;164A(7):1713–33. https://doi.org/10.1002/ajmg.a.36552 [published Online First: 2014/05/02].
39.
go back to reference Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A(2):287–95. https://doi.org/10.1002/ajmg.a.36836 [published Online First: 2015/01/06].
Keppler-Noreuil KM, Rios JJ, Parker VE, et al. PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation. Am J Med Genet A. 2015;167A(2):287–95. https://doi.org/10.1002/ajmg.a.36836 [published Online First: 2015/01/06].
40.
go back to reference Herricks JR, Hotez PJ, Wanga V, et al. The global burden of disease study 2013: What does it mean for the NTDs? PLoS Negl Trop Dis. 2017;11(8):e0005424. https://doi.org/10.1371/journal.pntd.0005424 [published Online First: 2017/08/05].
Herricks JR, Hotez PJ, Wanga V, et al. The global burden of disease study 2013: What does it mean for the NTDs? PLoS Negl Trop Dis. 2017;11(8):e0005424. https://doi.org/10.1371/journal.pntd.0005424 [published Online First: 2017/08/05].
41.
go back to reference Nagai Y, Aoyama K, Endo Y, et al. Lymphedema of the extremities developed as the initial manifestation of rheumatoid arthritis. Eur J Dermatol. 2007;17(2):175–6.
Nagai Y, Aoyama K, Endo Y, et al. Lymphedema of the extremities developed as the initial manifestation of rheumatoid arthritis. Eur J Dermatol. 2007;17(2):175–6.
42.
go back to reference Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol. 2006;15(3):153–65. https://doi.org/10.1016/j.suronc.2006.11.003 [published Online First: 2006/12/26].
Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol. 2006;15(3):153–65. https://doi.org/10.1016/j.suronc.2006.11.003 [published Online First: 2006/12/26].
43.
go back to reference Stoberl C, Partsch H. [Erysipelas and lymphedema–egg or hen?]. Z Hautkr. 1987;62(1):56–62 [published Online First: 1987/01/01].
Stoberl C, Partsch H. [Erysipelas and lymphedema–egg or hen?]. Z Hautkr. 1987;62(1):56–62 [published Online First: 1987/01/01].
44.
go back to reference DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15. https://doi.org/10.1016/S1470-2045(13)70076-7.CrossRefPubMed
DiSipio T, Rye S, Newman B, et al. Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol. 2013;14(6):500–15. https://doi.org/10.1016/S1470-2045(13)70076-7.CrossRefPubMed
45.
go back to reference Finegold DN, Baty CJ, Knickelbein KZ, et al. Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res. 2012;18(8):2382–90. https://doi.org/10.1158/1078-0432.ccr-11-2303 [published Online First: 2012/02/22].
Finegold DN, Baty CJ, Knickelbein KZ, et al. Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res. 2012;18(8):2382–90. https://doi.org/10.1158/1078-0432.ccr-11-2303 [published Online First: 2012/02/22].
46.
go back to reference Damstra RJ, Mortimer PS. Diagnosis and therapy in children with lymphoedema. Phlebology. 2008;23(6):276–86. https://doi.org/10.1258/phleb.2008.008010 [published Online First: 2008/11/26].
Damstra RJ, Mortimer PS. Diagnosis and therapy in children with lymphoedema. Phlebology. 2008;23(6):276–86. https://doi.org/10.1258/phleb.2008.008010 [published Online First: 2008/11/26].
47.
go back to reference Kinmonth JB, Taylor GW, Tracy GD, et al. Primary lymphoedema; clinical and lymphangiographic studies of a series of 107 patients in which the lower limbs were affected. Br J Surg. 1957;45(189):1–9. https://doi.org/10.1002/bjs.18004518902 [published Online First: 1957/07/01].
Kinmonth JB, Taylor GW, Tracy GD, et al. Primary lymphoedema; clinical and lymphangiographic studies of a series of 107 patients in which the lower limbs were affected. Br J Surg. 1957;45(189):1–9. https://doi.org/10.1002/bjs.18004518902 [published Online First: 1957/07/01].
48.
go back to reference Partsch H, Stoberl C, Urbanek A, et al. Clinical use of indirect lymphography in different forms of leg edema. Lymphology. 1988;21(3):152–60 [published Online First: 1988/09/01].
Partsch H, Stoberl C, Urbanek A, et al. Clinical use of indirect lymphography in different forms of leg edema. Lymphology. 1988;21(3):152–60 [published Online First: 1988/09/01].
49.
go back to reference Itkin M. Lymphatic intervention is a new frontier of IR. J Vasc Interv Radiol. 2014;25(9):1404–5. https://doi.org/10.1016/j.jvir.2014.06.004 [published Online First: 2014/08/26].
Itkin M. Lymphatic intervention is a new frontier of IR. J Vasc Interv Radiol. 2014;25(9):1404–5. https://doi.org/10.1016/j.jvir.2014.06.004 [published Online First: 2014/08/26].
50.
go back to reference Hayashi A, Visconti G, Yamamoto T, et al. Intraoperative imaging of lymphatic vessel using ultra high-frequency ultrasound. J Plast Reconstr Aesthet Surg JPRAS. 2018;71(5):778–80. https://doi.org/10.1016/j.bjps.2018.01.013 [published Online First: 2018/02/06].
Hayashi A, Visconti G, Yamamoto T, et al. Intraoperative imaging of lymphatic vessel using ultra high-frequency ultrasound. J Plast Reconstr Aesthet Surg JPRAS. 2018;71(5):778–80. https://doi.org/10.1016/j.bjps.2018.01.013 [published Online First: 2018/02/06].
51.
go back to reference Barrett T, Choyke PL, Kobayashi H. Imaging of the lymphatic system: new horizons. Contrast Media Mol Imag. 2006;1(6):230–45. https://doi.org/10.1002/cmmi.116 [published Online First: 2006/12/29].
Barrett T, Choyke PL, Kobayashi H. Imaging of the lymphatic system: new horizons. Contrast Media Mol Imag. 2006;1(6):230–45. https://doi.org/10.1002/cmmi.116 [published Online First: 2006/12/29].
52.
go back to reference Lee BB, Andrade M, Antignani PL, et al. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013. Int Angiol. 2013;32(6):541–74 [published Online First: 2013/11/12].
Lee BB, Andrade M, Antignani PL, et al. Diagnosis and treatment of primary lymphedema. Consensus document of the International Union of Phlebology (IUP)-2013. Int Angiol. 2013;32(6):541–74 [published Online First: 2013/11/12].
53.
go back to reference White RD, Weir-McCall JR, Budak MJ, et al. Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema. Clin Radiol. 2014;69(11):e435–44. https://doi.org/10.1016/j.crad.2014.06.007 [published Online First: 2014/07/30].
White RD, Weir-McCall JR, Budak MJ, et al. Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema. Clin Radiol. 2014;69(11):e435–44. https://doi.org/10.1016/j.crad.2014.06.007 [published Online First: 2014/07/30].
54.
go back to reference Sherman AI, Ter-Pogossian M. Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer. 1953;6(6):1238–40. https://doi.org/10.1002/1097-0142(195311)6:6%3c1238::aid-cncr2820060618%3e3.0.co;2-6 [published Online First: 1953/11/01].
Sherman AI, Ter-Pogossian M. Lymph-node concentration of radioactive colloidal gold following interstitial injection. Cancer. 1953;6(6):1238–40. https://doi.org/10.1002/1097-0142(195311)6:6%3c1238::aid-cncr2820060618%3e3.0.co;2-6 [published Online First: 1953/11/01].
55.
go back to reference Henze E, Schelbert HR, Collins JD, et al. Lymphoscintigraphy with Tc-99m-labeled dextran. J Nucl Med. 1982;23(10):923–9 [published Online First: 1982/10/01].
Henze E, Schelbert HR, Collins JD, et al. Lymphoscintigraphy with Tc-99m-labeled dextran. J Nucl Med. 1982;23(10):923–9 [published Online First: 1982/10/01].
56.
go back to reference Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology. 1988;167(3):729–35. https://doi.org/10.1148/radiology.167.3.3363131 [published Online First: 1988/06/01].
Weissleder H, Weissleder R. Lymphedema: evaluation of qualitative and quantitative lymphoscintigraphy in 238 patients. Radiology. 1988;167(3):729–35. https://doi.org/10.1148/radiology.167.3.3363131 [published Online First: 1988/06/01].
57.
go back to reference Szuba A, Shin WS, Strauss HW, et al. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44(1):43–57 [published Online First: 2003/01/08].
Szuba A, Shin WS, Strauss HW, et al. The third circulation: radionuclide lymphoscintigraphy in the evaluation of lymphedema. J Nucl Med. 2003;44(1):43–57 [published Online First: 2003/01/08].
58.
go back to reference Devoogdt N, Van den Wyngaert T, Bourgeois P, et al. Reproducibility of lymphoscintigraphic evaluation of the upper limb. Lymphat Res Biol. 2014;12(3):175–84. https://doi.org/10.1089/lrb.2013.0034.CrossRefPubMed
Devoogdt N, Van den Wyngaert T, Bourgeois P, et al. Reproducibility of lymphoscintigraphic evaluation of the upper limb. Lymphat Res Biol. 2014;12(3):175–84. https://doi.org/10.1089/lrb.2013.0034.CrossRefPubMed
59.
go back to reference Aldrich MB, Guilliod R, Fife CE, et al. Lymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging. Biomed Opt Express. 2012;3(6):1256–65. https://doi.org/10.1364/boe.3.001256 [published Online First: 2012/06/29].
Aldrich MB, Guilliod R, Fife CE, et al. Lymphatic abnormalities in the normal contralateral arms of subjects with breast cancer-related lymphedema as assessed by near-infrared fluorescent imaging. Biomed Opt Express. 2012;3(6):1256–65. https://doi.org/10.1364/boe.3.001256 [published Online First: 2012/06/29].
60.
go back to reference Thomis S, Dams L, Fourneau I, et al. Correlation Between Clinical Assessment And Lymphofluoroscopy In Patients With Breast Cancer-Related Lymphedema: A Study Of Concurrent Validity. Lymphat Res Biol. 2020. https://doi.org/10.1089/lrb.2019.0090 [published Online First: 2020/03/27].
Thomis S, Dams L, Fourneau I, et al. Correlation Between Clinical Assessment And Lymphofluoroscopy In Patients With Breast Cancer-Related Lymphedema: A Study Of Concurrent Validity. Lymphat Res Biol. 2020. https://doi.org/10.1089/lrb.2019.0090 [published Online First: 2020/03/27].
61.
go back to reference Devoogdt N, Pans S, De Groef A, et al. Postoperative evolution of thickness and echogenicity of cutis and subcutis of patients with and without breast cancer-related lymphedema. Lymphat Res Biol. 2014;12(1):23–31. https://doi.org/10.1089/lrb.2013.0028.CrossRefPubMed
Devoogdt N, Pans S, De Groef A, et al. Postoperative evolution of thickness and echogenicity of cutis and subcutis of patients with and without breast cancer-related lymphedema. Lymphat Res Biol. 2014;12(1):23–31. https://doi.org/10.1089/lrb.2013.0028.CrossRefPubMed
62.
go back to reference Naouri M, Samimi M, Atlan M, et al. High-resolution cutaneous ultrasonography to differentiate lipoedema from lymphoedema. Br J Dermatol. 2010;163(2):296–301. https://doi.org/10.1111/j.1365-2133.2010.09810.x [published Online First: 2010/04/23].
Naouri M, Samimi M, Atlan M, et al. High-resolution cutaneous ultrasonography to differentiate lipoedema from lymphoedema. Br J Dermatol. 2010;163(2):296–301. https://doi.org/10.1111/j.1365-2133.2010.09810.x [published Online First: 2010/04/23].
63.
go back to reference Nelzen O, Bergqvist D, Lindhagen A. The prevalence of chronic lower-limb ulceration has been underestimated: results of a validated population questionnaire. Br J Surg. 1996;83(2):255–8. [published Online First: 1996/02/01].
Nelzen O, Bergqvist D, Lindhagen A. The prevalence of chronic lower-limb ulceration has been underestimated: results of a validated population questionnaire. Br J Surg. 1996;83(2):255–8. [published Online First: 1996/02/01].
64.
go back to reference Charpy J, Audier M. Les troubles trophiques des membres inférieurs d’orgine veineuse: Masson. 1956.
Charpy J, Audier M. Les troubles trophiques des membres inférieurs d’orgine veineuse: Masson. 1956.
65.
go back to reference Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248–52. https://doi.org/10.1016/j.jvs.2004.09.027 [published Online First: 2004/12/29].
Eklof B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248–52. https://doi.org/10.1016/j.jvs.2004.09.027 [published Online First: 2004/12/29].
66.
go back to reference Callam MJ, Ruckley CV, Harper DR, et al. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J (Clin Res Ed). 1985;290(6485):1855–6. https://doi.org/10.1136/bmj.290.6485.1855 [published Online First: 1985/06/22].
Callam MJ, Ruckley CV, Harper DR, et al. Chronic ulceration of the leg: extent of the problem and provision of care. Br Med J (Clin Res Ed). 1985;290(6485):1855–6. https://doi.org/10.1136/bmj.290.6485.1855 [published Online First: 1985/06/22].
67.
go back to reference Burnand KG, Whimster I, Naidoo A, et al. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J (Clin Res Ed). 1982;285(6348):1071–2. https://doi.org/10.1136/bmj.285.6348.1071 [published Online First: 1982/10/16].
Burnand KG, Whimster I, Naidoo A, et al. Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration. Br Med J (Clin Res Ed). 1982;285(6348):1071–2. https://doi.org/10.1136/bmj.285.6348.1071 [published Online First: 1982/10/16].
68.
go back to reference Maessen-Visch MB, Neumann HAM, Koedam MI, et al. Répercussions de l’atrophie blanche sur les patients atteints d’un ulcus cruris venosum. Phlébologie. 1997;50:367–70.
Maessen-Visch MB, Neumann HAM, Koedam MI, et al. Répercussions de l’atrophie blanche sur les patients atteints d’un ulcus cruris venosum. Phlébologie. 1997;50:367–70.
69.
go back to reference Van der Veer G, Eekhof JAH, Walma EP, et al. NHG-standaarden voor de huisarts I: Elsevier/Bunge; 1999. pag. 349–55.
Van der Veer G, Eekhof JAH, Walma EP, et al. NHG-standaarden voor de huisarts I: Elsevier/Bunge; 1999. pag. 349–55.
70.
go back to reference Püschel K, Hoops E, Lignitz E. Fatale blutungen aus unterschenkelvarizes. Phlebol u Proktol. 1987;16:162.
Püschel K, Hoops E, Lignitz E. Fatale blutungen aus unterschenkelvarizes. Phlebol u Proktol. 1987;16:162.
71.
go back to reference Chiesa R, Marone EM, Limoni C, et al. Chronic venous disorders: correlation between visible signs, symptoms, and presence of functional disease. J Vasc Surg. 2007;46(2):322–30. https://doi.org/10.1016/j.jvs.2007.04.030 [published Online First: 2007/06/30].
Chiesa R, Marone EM, Limoni C, et al. Chronic venous disorders: correlation between visible signs, symptoms, and presence of functional disease. J Vasc Surg. 2007;46(2):322–30. https://doi.org/10.1016/j.jvs.2007.04.030 [published Online First: 2007/06/30].
72.
go back to reference Vuylsteke ME, Thomis S, Guillaume G, et al. Epidemiological study on chronic venous disease in Belgium and Luxembourg: prevalence, risk factors, and symptomatology. Eur J Vasc Endovasc Surg. 2015;49(4):432–9. https://doi.org/10.1016/j.ejvs.2014.12.031 [published Online First: 2015/02/24].
Vuylsteke ME, Thomis S, Guillaume G, et al. Epidemiological study on chronic venous disease in Belgium and Luxembourg: prevalence, risk factors, and symptomatology. Eur J Vasc Endovasc Surg. 2015;49(4):432–9. https://doi.org/10.1016/j.ejvs.2014.12.031 [published Online First: 2015/02/24].
73.
go back to reference Cornu-Thenard A, Boivin P, Baud JM, et al. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol. 1994;20(5):318–26. https://doi.org/10.1111/j.1524-4725.1994.tb01631.x [published Online First: 1994/05/01].
Cornu-Thenard A, Boivin P, Baud JM, et al. Importance of the familial factor in varicose disease. Clinical study of 134 families. J Dermatol Surg Oncol. 1994;20(5):318–26. https://doi.org/10.1111/j.1524-4725.1994.tb01631.x [published Online First: 1994/05/01].
74.
go back to reference Richtlijn ‘Diepe veneuze trombose en longembolie’: Kwaliteitsinstituut voor de gezondheidszorg CBO, 1999:26.
Richtlijn ‘Diepe veneuze trombose en longembolie’: Kwaliteitsinstituut voor de gezondheidszorg CBO, 1999:26.
75.
go back to reference May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8(5):419–27. https://doi.org/10.1177/000331975700800505 [published Online First: 1957/10/01].
May R, Thurner J. The cause of the predominantly sinistral occurrence of thrombosis of the pelvic veins. Angiology. 1957;8(5):419–27. https://doi.org/10.1177/000331975700800505 [published Online First: 1957/10/01].
76.
go back to reference Kappert A. Phlegmasia coerulea dolens. Bern, Huber: Hringer H. Akute tiefe Becken- und Beinvenenthrombosen; 1977.
Kappert A. Phlegmasia coerulea dolens. Bern, Huber: Hringer H. Akute tiefe Becken- und Beinvenenthrombosen; 1977.
77.
go back to reference Feuerstein W. Die diagnose des postthrombotischen syndroms. Phlebol u Proktol. 1979;8.
Feuerstein W. Die diagnose des postthrombotischen syndroms. Phlebol u Proktol. 1979;8.
78.
go back to reference Lochner J, Agathos M, Geier J, et al. Die Bedeutung von Kontaktallergien bei der Behandlung alterer Menschen mit Stauungsdermatitis. Phlebologie. 1997;26:111–4.
Lochner J, Agathos M, Geier J, et al. Die Bedeutung von Kontaktallergien bei der Behandlung alterer Menschen mit Stauungsdermatitis. Phlebologie. 1997;26:111–4.
79.
go back to reference Cavezzi A, Labropoulos N, Partsch H, et al. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs–UIP consensus document. Part II. Anatomy. Eur J Vasc Endovasc Surg. 2006;31(3):288–99. https://doi.org/10.1016/j.ejvs.2005.07.020 [published Online First: 2005/10/19].
Cavezzi A, Labropoulos N, Partsch H, et al. Duplex ultrasound investigation of the veins in chronic venous disease of the lower limbs–UIP consensus document. Part II. Anatomy. Eur J Vasc Endovasc Surg. 2006;31(3):288–99. https://doi.org/10.1016/j.ejvs.2005.07.020 [published Online First: 2005/10/19].
80.
go back to reference Kurstjens RL, De Wolf MA, Alsadah SA, et al. The value of hemodynamic measurements by air plethysmography in diagnosing venous obstruction of the lower limb. J Vasc Surg Venous Lymphat Disord. 2016;4(3):313–9. https://doi.org/10.1016/j.jvsv.2016.01.005 [published Online First: 2016/06/19].
Kurstjens RL, De Wolf MA, Alsadah SA, et al. The value of hemodynamic measurements by air plethysmography in diagnosing venous obstruction of the lower limb. J Vasc Surg Venous Lymphat Disord. 2016;4(3):313–9. https://doi.org/10.1016/j.jvsv.2016.01.005 [published Online First: 2016/06/19].
81.
go back to reference Peschen M, Vanscheidt W, Sigmund G, et al. Computertomographische und magnetresonanzttomographische Untersuchungen vor und nach paratibialer Fasziotomie. Hautarzt. 1996;47(7):521–5.CrossRef
Peschen M, Vanscheidt W, Sigmund G, et al. Computertomographische und magnetresonanzttomographische Untersuchungen vor und nach paratibialer Fasziotomie. Hautarzt. 1996;47(7):521–5.CrossRef
82.
go back to reference Wittens C, Davies AH, Baekgaard N, et al. Editor’s choice – management of chronic venous disease: clinical practice guidelines of the european society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49(6):678–737. https://doi.org/10.1016/j.ejvs.2015.02.007 [published Online First: 2015/04/30].
Wittens C, Davies AH, Baekgaard N, et al. Editor’s choice – management of chronic venous disease: clinical practice guidelines of the european society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg. 2015;49(6):678–737. https://doi.org/10.1016/j.ejvs.2015.02.007 [published Online First: 2015/04/30].
83.
go back to reference Conte MS, Pomposelli FB. Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. J Vasc Surg. 2015;61(3 Suppl):1S. https://doi.org/10.1016/j.jvs.2014.12.006 [published Online First: 2015/02/28].
Conte MS, Pomposelli FB. Society for vascular surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. J Vasc Surg. 2015;61(3 Suppl):1S. https://doi.org/10.1016/j.jvs.2014.12.006 [published Online First: 2015/02/28].
84.
go back to reference Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1–S109 e33. https://doi.org/10.1016/j.ejvs.2019.05.006 [published Online First: 2019/06/12].
Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg. 2019;58(1S):S1–S109 e33. https://doi.org/10.1016/j.ejvs.2019.05.006 [published Online First: 2019/06/12].
85.
go back to reference Richtlijn Perifeer Arterieel Vaatlijden (PAV). In: (FMS) FMs, ed. Nederland, 2016.
Richtlijn Perifeer Arterieel Vaatlijden (PAV). In: (FMS) FMs, ed. Nederland, 2016.
86.
go back to reference Hardman RL, Jazaeri O, Yi J, et al. Overview of classification systems in peripheral artery disease. Semin Intervent Radiol. 2014;31(4):378–88. https://doi.org/10.1055/s-0034-1393976 [published Online First: 2014/12/02].
Hardman RL, Jazaeri O, Yi J, et al. Overview of classification systems in peripheral artery disease. Semin Intervent Radiol. 2014;31(4):378–88. https://doi.org/10.1055/s-0034-1393976 [published Online First: 2014/12/02].
87.
go back to reference Lavrijsen APM, Damstra RJ, Van Dissel JT, et al. Richtlijn cellulitis en erysipelas van de onderste extremiteiten. 2013. [Available from: https://www.alii.care//engine/download/blob/alii/470/2019/41/20190717_richtlijn-erysipelas-en-cellulitis-definitief.pdf?app=alii&class=74&id=2159&field=470 [last accessed 22-1-2019]].
Lavrijsen APM, Damstra RJ, Van Dissel JT, et al. Richtlijn cellulitis en erysipelas van de onderste extremiteiten. 2013. [Available from: https://www.alii.care//engine/download/blob/alii/470/2019/41/20190717_richtlijn-erysipelas-en-cellulitis-definitief.pdf?app=alii&class=74&id=2159&field=470 [last accessed 22-1-2019]].
88.
go back to reference Chlebicki MP, Oh CC. Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment. Curr Infect Dis Rep. 2014;16(9):422. https://doi.org/10.1007/s11908-014-0422-0 [published Online First: 2014/07/02].
Chlebicki MP, Oh CC. Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment. Curr Infect Dis Rep. 2014;16(9):422. https://doi.org/10.1007/s11908-014-0422-0 [published Online First: 2014/07/02].
89.
go back to reference Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol. 2006;20(7):834–9. https://doi.org/10.1111/j.1468-3083.2006.01657.x [published Online First: 2006/08/11].
Goettsch WG, Bouwes Bavinck JN, Herings RM. Burden of illness of bacterial cellulitis and erysipelas of the leg in the Netherlands. J Eur Acad Dermatol Venereol. 2006;20(7):834–9. https://doi.org/10.1111/j.1468-3083.2006.01657.x [published Online First: 2006/08/11].
90.
go back to reference Cranendonk DR, Lavrijsen APM, Prins JM, et al. Cellulitis: current insights into pathophysiology and clinical management. Neth J Med. 2017;75(9):366–78 [published Online First: 2017/12/09].
Cranendonk DR, Lavrijsen APM, Prins JM, et al. Cellulitis: current insights into pathophysiology and clinical management. Neth J Med. 2017;75(9):366–78 [published Online First: 2017/12/09].
91.
go back to reference Bartholomeeusen S, Vandenbroucke J, Truyers C, et al. Epidemiology and comorbidity of erysipelas in primary care. Dermatology. 2007;215(2):118–22. https://doi.org/10.1159/000104262 [published Online First: 2007/08/09].
Bartholomeeusen S, Vandenbroucke J, Truyers C, et al. Epidemiology and comorbidity of erysipelas in primary care. Dermatology. 2007;215(2):118–22. https://doi.org/10.1159/000104262 [published Online First: 2007/08/09].
92.
go back to reference Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas–risk factors and clinical presentation. BMC Infect Dis. 2014;14:270. https://doi.org/10.1186/1471-2334-14-270 [published Online First: 2014/06/03].
Inghammar M, Rasmussen M, Linder A. Recurrent erysipelas–risk factors and clinical presentation. BMC Infect Dis. 2014;14:270. https://doi.org/10.1186/1471-2334-14-270 [published Online First: 2014/06/03].
93.
go back to reference Eells SJ, Chira S, David CG, et al. Non-suppurative cellulitis: risk factors and its association with Staphylococcus aureus colonization in an area of endemic community-associated methicillin-resistant S. aureus infections. Epidemiol Infect. 2011;139(4):606–12. https://doi.org/10.1017/s0950268810001408 [published Online First: 2010/06/22].
Eells SJ, Chira S, David CG, et al. Non-suppurative cellulitis: risk factors and its association with Staphylococcus aureus colonization in an area of endemic community-associated methicillin-resistant S. aureus infections. Epidemiol Infect. 2011;139(4):606–12. https://doi.org/10.1017/s0950268810001408 [published Online First: 2010/06/22].
94.
go back to reference Levell NJ, Wingfield CG, Garioch JJ. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care. Br J Dermatol. 2011;164(6):1326–8. https://doi.org/10.1111/j.1365-2133.2011.10275.x [published Online First: 2011/05/14].
Levell NJ, Wingfield CG, Garioch JJ. Severe lower limb cellulitis is best diagnosed by dermatologists and managed with shared care between primary and secondary care. Br J Dermatol. 2011;164(6):1326–8. https://doi.org/10.1111/j.1365-2133.2011.10275.x [published Online First: 2011/05/14].
95.
go back to reference Strazzula L, Cotliar J, Fox LP, et al. Inpatient dermatology consultation aids diagnosis of cellulitis among hospitalized patients: A multi-institutional analysis. J Am Acad Dermatol. 2015;73(1):70–5. https://doi.org/10.1016/j.jaad.2014.11.012 [published Online First: 2015/06/20].
Strazzula L, Cotliar J, Fox LP, et al. Inpatient dermatology consultation aids diagnosis of cellulitis among hospitalized patients: A multi-institutional analysis. J Am Acad Dermatol. 2015;73(1):70–5. https://doi.org/10.1016/j.jaad.2014.11.012 [published Online First: 2015/06/20].
96.
go back to reference Weng QY, Raff AB, Cohen JM, et al. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2016. https://doi.org/10.1001/jamadermatol.2016.3816.CrossRefPubMed
Weng QY, Raff AB, Cohen JM, et al. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2016. https://doi.org/10.1001/jamadermatol.2016.3816.CrossRefPubMed
97.
go back to reference Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics: part II. Conditions that simulate lower limb cellulitis. J Am Acad Dermatol. 2012;67(2):177 e1–9; quiz 85–6. https://doi.org/10.1016/j.jaad.2012.03.023 [published Online First: 2012/07/17].
Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics: part II. Conditions that simulate lower limb cellulitis. J Am Acad Dermatol. 2012;67(2):177 e1–9; quiz 85–6. https://doi.org/10.1016/j.jaad.2012.03.023 [published Online First: 2012/07/17].
98.
go back to reference Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. In: Organization WH, ed. Geneva; 2011.
Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. In: Organization WH, ed. Geneva; 2011.
99.
go back to reference WHO. Lymphatic Filariasis report 2019.
WHO. Lymphatic Filariasis report 2019.
100.
go back to reference Organization WH. Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis; Licence: CC BY-NC-SA 3.0 IGO, 2017.
Organization WH. Guideline: alternative mass drug administration regimens to eliminate lymphatic filariasis; Licence: CC BY-NC-SA 3.0 IGO, 2017.
101.
go back to reference Dreyer G, Noroes J, Figueredo-Silva J, et al. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today. 2000;16(12):544–8. https://doi.org/10.1016/s0169-4758(00)01778-6 [published Online First: 2000/12/21].
Dreyer G, Noroes J, Figueredo-Silva J, et al. Pathogenesis of lymphatic disease in bancroftian filariasis: a clinical perspective. Parasitol Today. 2000;16(12):544–8. https://doi.org/10.1016/s0169-4758(00)01778-6 [published Online First: 2000/12/21].
102.
go back to reference Pani SP, Srividya A. Clinical manifestations of bancroftian filariasis with special reference to lymphoedema grading. Indian J Med Res. 1995;102:114–8 [published Online First: 1995/09/01].
Pani SP, Srividya A. Clinical manifestations of bancroftian filariasis with special reference to lymphoedema grading. Indian J Med Res. 1995;102:114–8 [published Online First: 1995/09/01].
103.
go back to reference Olszewski WL, Jamal S, Manokaran G, et al. Skin changes in filarial and non-filarial lymphoedema of the lower extremities. Trop Med Parasitol. 1993;44(1):40–4. [published Online First: 1993/03/01].
Olszewski WL, Jamal S, Manokaran G, et al. Skin changes in filarial and non-filarial lymphoedema of the lower extremities. Trop Med Parasitol. 1993;44(1):40–4. [published Online First: 1993/03/01].
104.
go back to reference Davey G, Tekola F, Newport MJ. Podoconiosis: non-infectious geochemical elephantiasis. Trans R Soc Trop Med Hyg. 2007;101(12):1175–80. https://doi.org/10.1016/j.trstmh.2007.08.013 [published Online First: 2007/11/03].
Davey G, Tekola F, Newport MJ. Podoconiosis: non-infectious geochemical elephantiasis. Trans R Soc Trop Med Hyg. 2007;101(12):1175–80. https://doi.org/10.1016/j.trstmh.2007.08.013 [published Online First: 2007/11/03].
105.
go back to reference Price E. Podoconiosis: non-filarial Elephantiasis. Oxford: Oxford Medical; 1990.
Price E. Podoconiosis: non-filarial Elephantiasis. Oxford: Oxford Medical; 1990.
106.
go back to reference Price EW, Henderson WJ. The elemental content of lymphatic tissues of barefooted people in Ethiopia, with reference to endemic elephantiasis of the lower legs. Trans R Soc Trop Med Hyg. 1978;72(2):132–6. https://doi.org/10.1016/0035-9203(78)90048-2 [published Online First: 1978/01/01].
Price EW, Henderson WJ. The elemental content of lymphatic tissues of barefooted people in Ethiopia, with reference to endemic elephantiasis of the lower legs. Trans R Soc Trop Med Hyg. 1978;72(2):132–6. https://doi.org/10.1016/0035-9203(78)90048-2 [published Online First: 1978/01/01].
107.
go back to reference Wendemagegn E, Tirumalae R, Boer-Auer A. Histopathological and immunohistochemical features of nodular podoconiosis. J Cutan Pathol. 2015;42(3):173–81. https://doi.org/10.1111/cup.12441 [published Online First: 2014/11/18].
Wendemagegn E, Tirumalae R, Boer-Auer A. Histopathological and immunohistochemical features of nodular podoconiosis. J Cutan Pathol. 2015;42(3):173–81. https://doi.org/10.1111/cup.12441 [published Online First: 2014/11/18].
108.
go back to reference Tekola-Ayele F, Wendemagegn E. Podoconiosis: tropical lymphedema of the lower legs. In: Ltd iP, ed. Dermatology and allergology – principles and practice. Hong Kong; 2014.
Tekola-Ayele F, Wendemagegn E. Podoconiosis: tropical lymphedema of the lower legs. In: Ltd iP, ed. Dermatology and allergology – principles and practice. Hong Kong; 2014.
109.
go back to reference Sikorski C, Ashine M, Zeleke Z, et al. Effectiveness of a simple lymphoedema treatment regimen in podoconiosis management in southern ethiopia: one year follow-up. PLoS Negl Trop Dis. 2010;4(11):e902. https://doi.org/10.1371/journal.pntd.0000902 [published Online First: 2010/12/15].
Sikorski C, Ashine M, Zeleke Z, et al. Effectiveness of a simple lymphoedema treatment regimen in podoconiosis management in southern ethiopia: one year follow-up. PLoS Negl Trop Dis. 2010;4(11):e902. https://doi.org/10.1371/journal.pntd.0000902 [published Online First: 2010/12/15].
110.
go back to reference Griffiths C, Barker J, Bleiker T, et al. Rook’s textbook of dermatology; 9th revised edition: Wiley & sons; 2016.
Griffiths C, Barker J, Bleiker T, et al. Rook’s textbook of dermatology; 9th revised edition: Wiley & sons; 2016.
Metagegevens
- Titel
- Medische diagnostiek
- Auteurs
-
Robert Damstra, PhD, MD
Kristiana Gordon, PhD, MD
Malou van Zanten, PhD, PT
Sahar Mansour, PhD, MD
Kirsten van Duinen, MD
Sarah Thomis, MSc
Nele Devoogdt, PhD, PT
Inge Fourneau, PhD, MD
Sjan Lavrijsen, PhD, MD
Wendemagegn Enbiale, MD
Michette de Rooij, PhD, MD
- Copyright
- 2021
- Uitgeverij
- Bohn Stafleu van Loghum
- Boek
-
Oedeem en oedeemtherapie
Print ISBN: 978-90-368-2589-4
Elektronisch ISBN: 978-90-368-2590-0
Copyright: 2021
- DOI
- https://doi.org/10.1007/978-90-368-2590-0_2